Dutch tariff for the five-level version of EQ-5D MM Versteegh, KM Vermeulen, SMAA Evers, GA De Wit, R Prenger, ... Value in health 19 (4), 343-352, 2016 | 924 | 2016 |
Age-specific incidence and prevalence of keratoconus: a nationwide registration study DA Godefrooij, GA De Wit, CS Uiterwaal, SM Imhof, RPL Wisse American journal of ophthalmology 175, 169-172, 2017 | 546 | 2017 |
Lifetime medical costs of obesity: prevention no cure for increasing health expenditure PHM van Baal, JJ Polder, GA de Wit, RT Hoogenveen, TL Feenstra, ... PLoS medicine 5 (2), e29, 2008 | 364 | 2008 |
Economic evaluation of end stage renal disease treatment GA De Wit, PG Ramsteijn, FT de Charro Health policy 44 (3), 215-232, 1998 | 286 | 1998 |
Sensitivity and perspective in the valuation of health status: whose values count? GA De Wit, JJV Busschbach, FT De Charro Health economics 9 (2), 109-126, 2000 | 276 | 2000 |
The effect of including an opt-out option in discrete choice experiments J Veldwijk, MS Lambooij, EW de Bekker-Grob, HA Smit, GA de Wit PloS one 9 (11), e111805, 2014 | 210 | 2014 |
Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective IK Veldhuijzen, M Toy, SJM Hahné, GA De Wit, SW Schalm, RA de Man, ... Gastroenterology 138 (2), 522-530, 2010 | 184 | 2010 |
The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination H de Melker, G Berbers, S Hahné, H Rümke, S van den Hof, A de Wit, ... Vaccine 24 (18), 3946-3952, 2006 | 183 | 2006 |
Effectiveness and Efficiency of Controlling Campylobacter on Broiler Chicken Meat AH Havelaar, MJJ Mangen, AA De Koeijer, MJ Bogaardt, EG Evers, ... Risk Analysis: An International Journal 27 (4), 831-844, 2007 | 181 | 2007 |
Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment RW Sprengers, M Teraa, FL Moll, GA De Wit, Y Van Der Graaf, ... Journal of vascular surgery 52 (4), 843-849. e1, 2010 | 171 | 2010 |
Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis JP Greving, FLJ Visseren, GA De Wit, A Algra Bmj 342, 2011 | 155 | 2011 |
Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands MJJ Mangen, MH Rozenbaum, SM Huijts, CH van Werkhoven, ... European Respiratory Journal 46 (5), 1407-1416, 2015 | 150 | 2015 |
Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation IVF van den Broek, JEAM van Bergen, EEHG Brouwers, JSA Fennema, ... Bmj 345, 2012 | 134 | 2012 |
The impact of a healthy lifestyle on Disability-Adjusted Life Years: a prospective cohort study AM May, EA Struijk, HP Fransen, NC Onland-Moret, GA de Wit, JMA Boer, ... BMC medicine 13, 1-9, 2015 | 127 | 2015 |
Preventive exercises reduced injury-related costs among adult male amateur soccer players: a cluster-randomised trial MR Krist, AMC van Beijsterveldt, FJG Backx, GA de Wit Journal of physiotherapy 59 (1), 15-23, 2013 | 121 | 2013 |
Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis P Beutels, WJ Edmunds, F Antoñanzas, GA De Wit, D Evans, R Feilden, ... Pharmacoeconomics 20 (1), 1-7, 2002 | 120 | 2002 |
Rapid screening of methicillin‐resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects MWM Wassenberg, JAJW Kluytmans, ATA Box, RW Bosboom, ... Clinical microbiology and infection 16 (12), 1754-1761, 2010 | 119 | 2010 |
The impact of community-acquired pneumonia on the health-related quality-of-life in elderly MJJ Mangen, SM Huijts, MJM Bonten, GA de Wit BMC infectious diseases 17, 1-9, 2017 | 118 | 2017 |
Standardizing the inclusion of indirect medical costs in economic evaluations PHM van Baal, A Wong, LCJ Slobbe, JJ Polder, WBF Brouwer, GA de Wit Pharmacoeconomics 29, 175-187, 2011 | 114 | 2011 |
Consistency between stated and revealed preferences: a discrete choice experiment and a behavioural experiment on vaccination behaviour compared MS Lambooij, IA Harmsen, J Veldwijk, H de Melker, L Mollema, ... BMC medical research methodology 15, 1-8, 2015 | 111 | 2015 |